AKTIIA OBPM to Assess CPAP Effect on Blood Pressure in Obstructive Sleep Apnea

Launched by HOSPITAL UNIVERSITARIO ARABA · May 31, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether a treatment called CPAP (Continuous Positive Airway Pressure) can help control high blood pressure in adults who have obstructive sleep apnea (OSA) and undiagnosed high blood pressure. The researchers will use a special device called AKTIIA OBPM, which can monitor blood pressure without a traditional cuff, to gather information about how well CPAP works. They will also look at how CPAP affects heart function and gather feedback from participants about their experience using the AKTIIA device.

To participate, you need to be between 25 and 70 years old, have moderate to severe OSA, and be starting CPAP therapy for the first time. You should also have undiagnosed high blood pressure and be comfortable using a smartphone. Over 12 weeks, participants will use CPAP and the AKTIIA device, undergo heart tests, and complete an online survey about how easy the device is to use. This study is not yet recruiting participants, but it aims to help improve care for those with OSA and high blood pressure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults 25-70 years old
• • Moderate-severe OSA (AHI 15+)
• • First prescription of CPAP therapy
• • Undiagnosed HBP
• • Smartphone use and technological skills
• • Informed consent
• Exclusion Criteria:
• • Antihypertensive drug
• • Cardiovascular comorbidity: atrial fibrilation, heart failure, ischemic heart disease, stroke
• • Reduced perfusion (e.g. Raynaud)
• • Severe/Advanced chronic disease
• • Central apnea
• • Pregnancy
• • Shift work
• • Other social issues: misunderstanding/miscommunication